Search research articles
Contact Us
Filters
Showing results (121-130 of 157) with videos related to
Page
of 16
Sort By:
Clinical Genitourinary Cancer
|
September 19, 2015
Safety and Clinical Outcomes of Abiraterone Acetate After Docetaxel in Octogenarians With Metastatic Castration-Resistant Prostate Cancer: Results of the Italian Compassionate Use Named Patient Programme
Francesca Maines, Orazio Caffo, Ugo De Giorgi, et al.
BJU International
|
July 4, 2014
Safety and clinical outcomes of patients treated with abiraterone acetate after docetaxel: results of the Italian Named Patient Programme
Orazio Caffo, Ugo De Giorgi, Lucia Fratino, et al.
Frontiers in Oncology
|
October 14, 2022
Advanced low grade serous ovarian cancer: A retrospective analysis of surgical and chemotherapeutic management in two high volume oncological centers
Paolo Di Lorenzo, Vincenza Conteduca, Emanuela Scarpi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 13, 2025
Liquid Biopsy Identifies Taxane Resistance and Clonal Selection in Castration-Resistant Prostate Cancer
Nicole Brighi, Daniel Wetterskog, Osvaldas Vainauskas, et al.
European Urology
|
November 6, 2020
Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based Treatment
Vicenç Ruiz de Porras, Xieng C Wang, Luis Palomero, et al.
Prostate Cancer and Prostatic Diseases
|
February 12, 2024
Initial management approach for localized/locally advanced disease is critical to guide metastatic castration-resistant prostate cancer care
Vincenza Conteduca, Piergiorgio Di Tullio, Rossana Allamprese, et al.
Science Translational Medicine
|
November 6, 2015
Plasma AR and abiraterone-resistant prostate cancer
Alessandro Romanel, Delila Gasi Tandefelt, Vincenza Conteduca, et al.
The Oncologist
|
November 17, 2025
Best therapeutic approach in metastatic hormone-sensitive prostate cancer based on disease volume: a systematic review and network meta-analysis
Fabrizio Di Costanzo, Chiara Mercinelli, Alessio Signori, et al.
The Oncologist
|
August 3, 2022
Adherence to Oral Treatments in Older Patients with Advanced Prostate Cancer, the ADHERE Study: A Prospective Trial of the Meet-URO Network
Pasquale Rescigno, Marco Maruzzo, Sara Elena Rebuzzi, et al.
Science Translational Medicine
|
March 22, 2019
Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer
Loredana Puca, Katie Gavyert, Verena Sailer, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 157) with videos related to
Sort By:
Page
of 16
Clinical Genitourinary Cancer
|
September 19, 2015
Safety and Clinical Outcomes of Abiraterone Acetate After Docetaxel in Octogenarians With Metastatic Castration-Resistant Prostate Cancer: Results of the Italian Compassionate Use Named Patient Programme
Francesca Maines, Orazio Caffo, Ugo De Giorgi, et al.
BJU International
|
July 4, 2014
Safety and clinical outcomes of patients treated with abiraterone acetate after docetaxel: results of the Italian Named Patient Programme
Orazio Caffo, Ugo De Giorgi, Lucia Fratino, et al.
Frontiers in Oncology
|
October 14, 2022
Advanced low grade serous ovarian cancer: A retrospective analysis of surgical and chemotherapeutic management in two high volume oncological centers
Paolo Di Lorenzo, Vincenza Conteduca, Emanuela Scarpi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 13, 2025
Liquid Biopsy Identifies Taxane Resistance and Clonal Selection in Castration-Resistant Prostate Cancer
Nicole Brighi, Daniel Wetterskog, Osvaldas Vainauskas, et al.
European Urology
|
November 6, 2020
Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based Treatment
Vicenç Ruiz de Porras, Xieng C Wang, Luis Palomero, et al.
Prostate Cancer and Prostatic Diseases
|
February 12, 2024
Initial management approach for localized/locally advanced disease is critical to guide metastatic castration-resistant prostate cancer care
Vincenza Conteduca, Piergiorgio Di Tullio, Rossana Allamprese, et al.
Science Translational Medicine
|
November 6, 2015
Plasma AR and abiraterone-resistant prostate cancer
Alessandro Romanel, Delila Gasi Tandefelt, Vincenza Conteduca, et al.
The Oncologist
|
November 17, 2025
Best therapeutic approach in metastatic hormone-sensitive prostate cancer based on disease volume: a systematic review and network meta-analysis
Fabrizio Di Costanzo, Chiara Mercinelli, Alessio Signori, et al.
The Oncologist
|
August 3, 2022
Adherence to Oral Treatments in Older Patients with Advanced Prostate Cancer, the ADHERE Study: A Prospective Trial of the Meet-URO Network
Pasquale Rescigno, Marco Maruzzo, Sara Elena Rebuzzi, et al.
Science Translational Medicine
|
March 22, 2019
Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer
Loredana Puca, Katie Gavyert, Verena Sailer, et al.
Page
of 16